2.34
0.01 (0.43%)
| Previous Close | 2.33 |
| Open | 2.36 |
| Volume | 108,058 |
| Avg. Volume (3M) | 145,968 |
| Market Cap | 102,062,840 |
| Price / Sales | 0.930 |
| Price / Book | 1.40 |
| 52 Weeks Range | |
| Earnings Date | 5 Mar 2025 - 10 Mar 2025 |
| Profit Margin | -14.57% |
| Operating Margin (TTM) | -7.72% |
| Diluted EPS (TTM) | -0.330 |
| Quarterly Revenue Growth (YOY) | -13.40% |
| Total Debt/Equity (MRQ) | 70.29% |
| Current Ratio (MRQ) | 2.06 |
| Operating Cash Flow (TTM) | 4.02 M |
| Levered Free Cash Flow (TTM) | 6.06 M |
| Return on Assets (TTM) | -1.98% |
| Return on Equity (TTM) | -20.40% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Instruments & Supplies (US) | Mixed | Mixed |
| Medical Instruments & Supplies (Global) | Mixed | Mixed | |
| Stock | Harvard Bioscience, Inc. | Mixed | Mixed |
AIStockmoo Score
| Analyst Consensus | NA |
| Insider Activity | NA |
| Price Volatility | 1.5 |
| Technical Moving Averages | -2.5 |
| Technical Oscillators | -0.5 |
| Average | -0.50 |
|
Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, specialized products and services that enable fundamental research, discovery, and pre-clinical testing for drug development. Its primary focus is scientific instruments used to advance life sciences and research. With operations in North America, Europe and china it sells through a combination of direct and distribution channels to customers around the world. The product brands of the company include Harvard Apparatus, DSI, Buxco, Biochrom, BTX, Heka, Hugo Sachs, Multichannel Systems MCS GmbH, and Panlab.. The majority of its revenue comes from the United States. |
|
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| Investment Style | Small Value |
| % Held by Insiders | 7.77% |
| % Held by Institutions | 75.99% |
No data within this time range.
No data within this time range.
| Date | Type | Details |
|---|---|---|
| 07 Nov 2024 | Announcement | Harvard Bioscience Announces Third Quarter 2024 Financial Results |
| 29 Oct 2024 | Announcement | Harvard Bioscience Schedules Third Quarter 2024 Earnings Conference Call for November 7, 2024 at 8:00 AM ET |
| 03 Oct 2024 | Announcement | Harvard Bioscience to Showcase Innovative Technologies at Society for Neuroscience (SfN) Annual Meeting 2024 |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2024 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |